[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100652664":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":27,"responsibleParty":42,"collaborators":20,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":20,"eligibilityCriteria":52,"healthyVolunteers":53,"sex":54,"minAge":55,"maxAge":56,"enrollmentInfo":57,"targetDuration":20,"studyType":60,"phases":61,"briefSummary":63,"conditions":64,"keywords":68,"overallStatus":30,"whyStopped":20,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"University of Pennsylvania","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Filler","EXPERIMENTAL","HA filler to chin region",[13],"Drug: HA Filler",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","HA Filler","Patients will receive FDA approved dosages of filler to the lower face region to treat chin regression or contour the chin, as per FDA approved indications. Patients are limited to the maximum recommended injected dose per patient for the initial and re-treatment (touch-up) injections of 4 mL. The injected volume per injection site should not exceed 2mL, the maximum volume studied and established by the manufacturer. Prior to injections, patients will be imaged with 3-dimensional photogrammetry and take a validated survey questionnaire (FACE-Q). Subjects will return post-injection in 2 weeks, 1 month, and 3 months for re-imaging and FACE-Q survey completion.",[9],null,[22],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Aamirah McCutchen","CONTACT","215-360-0652","aamirah.mccutchen@pennmedicine.upenn.edu",[28],{"facility":29,"status":30,"city":31,"state":32,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":20},"Penn Medicine","RECRUITING","Philadelphia","Pennsylvania","19104","United States","US",{"type":37,"coordinates":38},"Point",[39,40],-75.16362,39.95238,{"lat":40,"lon":39},{"type":43,"investigatorFullName":44,"investigatorTitle":45,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"PRINCIPAL_INVESTIGATOR","Ivona Percec","Director, Cosmetic Surgery, Principal Investigator, Associate Professor of Clinical Surgery","100652664","phase-4-evaluation-of-filler-injection-for-chin-profile-enhancement-100652664",false,"NCT07777926","Evaluation of Filler Injection for Chin Profile Enhancement","3-Dimensional Volumetric Analysis of a Hyaluronic Filler Injection for Chin Profile Enhancement","Inclusion Criteria:\n\n* Age 22-55\n* Patients interested in chin profile enhancement.\n* Participants must sign the informed consent form.\n\nExclusion Criteria:\n\n* Prior filler for facial contouring\n* Filler injection within the past 12 months or during duration of study\n* Prior facial cosmetic surgery (i.e.. facelift)\n* Prior facial trauma (i.e.. orbital fracture)\n* Pregnant or breastfeeding at the time of injection (initial visit)\n* Planned dental work within next 2 weeks\n* The following contraindications: patients with known hypersensitivity or severe allergies manifested by a history of anaphylaxis or history or presence of multiple severe allergies, gram-positive bacterial protein allergies, lidocaine allergies or other local anesthetics of the amide type\n* Patients with known bleeding disorders",true,"ALL","22 Years","55 Years",{"count":58,"type":59},20,"ESTIMATED","INTERVENTIONAL",[62],"PHASE4","The goal of this prospective study is to analyze volumetric changes in the lower face after hyaluronic acid filler injections over 90 days.\n\nThe primary aim of the study is to quantify volume change of the lower face rea over time after injection of filler. The secondary aim is to collect patient related outcomes (PROs) via FACE-Q.\n\nParticipants will receive hyaluronic acid filler injections (Restylane Lyft(for contouring of the chin. Each patient will receive FDA approved dosages of filler to the lower face region to treat chin regression or chin contouring, as per FDA approved indications.\n\nPrior to injections patients will be imaged with 3-dimensional photogrammetry. Subjects will return post-injection in 2 weeks, 1 month, and 3 moths for re-imaging.",[65,66,67],"Chin Regression","Chin Asymmetry","Jawline Contour Deficit",[69,70,71,72,9,73,74,75,76,77],"jaw","Hyaluronic Acid","HA filler","Hyaluronic Acid filler","Cosmetic","face","dermal filler","chin","jawline","2026-08-18",{"date":80,"type":81},"2026-08-20","ACTUAL",{"date":83,"type":59},"2026-09-30",{"date":85,"type":59},"2026-12-01",{"name":5,"class":6},1]